Results 101 to 110 of about 9,672 (236)

Role of Direct Antiviral Agents in Treatment of Chronic Hepatitis C Infection in Renal Transplant Recipients

Journal of Transplantation, 2018
Background. Since the introduction of direct antiviral agents (DAAs), morbidity of HCV has considerably decreased but still no guidelines have been formulated in renal transplant recipients (RTRs). We studied efficacy and tolerability of direct antiviral
Sourabh Sharma, Debabrata Mukherjee, Ranjith K. Nair, Bhaskar Datt, Ananth Rao   +4 more
doaj   +1 more source

New perspectives for preventing hepatitis C virus liver graft infection [PDF]

, 2016
publisher: Elsevier articletitle: New perspectives for preventing hepatitis C virus liver graft infection journaltitle: The Lancet Infectious Diseases articlelink: http://dx.doi.org/10.1016/S1473-3099(16)00120-1 content_type: article copyright: © 2016 ...
Abdelmalek, Adam, Akazawa, Andre, Audrey Coilly, Bandiera, Bankwitz, Baumert, Benedicto, Berenguer, Berenguer, Berenguer, Berenguer, Bizollon, Blasco, Brown, Bzowej, Carrion, Carrion, Carrion, Chalasani, Charlton, Charlton, Charlton, Charlton, Chung, Ciesek, Coilly, Coilly, Coilly, Colpitts, Colpitts, Crespo, Curry, Curry, Daniel J Felmlee, Davis, de Jong, Denniston, Desombere, Deuffic-Burban, Didier Samuel, Fafi-Kremer, Faisal, Fauvelle, Feld, Felmlee, Firpi, Fofana, Fofana, Fofana, Forman, Forns, Forns, Foster, Foster, Fukasawa, Fukuhara, Gambato, Gane, Gane, Gerold, Guedj, Haberstroh, Haid, He, Helle, Hopcraft, Janssen, Ji, Jiang, Keck, Khan, Kim, Kong, Kugelmas, Kwo, Kwo, Lanford, Law, Leroy, Lin, Lupberger, Mailly, Manns, Manns, Marino, Martin, Martin, Masaki, Mazzaferro, Meuleman, Meuleman, Meuleman, Munoz, O'Shea, Ojo, Ouwerkerk-Mahadevan, Owsianka, Pawlotsky, Perin, Picciotto, Ploss, Ploss, Poordad, Prieto, Pungpapong, Raymond T Chung, Reddy, Roche, Rowe, Rowe, Sainz, Shergill, St Vincent, Sugawara, Sulkowski, Takaki, Terrault, Thomas F Baumert, Toso, Uprichard, Van Der Ree, Vanwolleghem, Veldt, Vercauteren, Vercauteren, von Hahn, Walter, Wang, Watt, Wedemeyer, Welker, Xiao, Xiao, Xirouchakis, Yamashita, Zahid, Zeisel, Zeisel, Zhang, Zhang, Zhu, Zona   +143 more
core   +4 more sources

A case of porphyria cutanea tarda in the setting of hepatitis C infection and tobacco usage [PDF]

, 2019
Porphyria cutanea tarda (PCT) is the most common type of porphyria, presenting in middle-aged patients with a photodistributed vesiculobullous eruption, milia, and scars.
Brinster, NK, Chen, L, Lederhandler, M, Meehan, SA, Neimann, A   +4 more
core  

Long-term outcomes of direct acting antivirals in post-transplant advanced hepatitis C virus recurrence and fibrosing cholestatic hepatitis. [PDF]

, 2017
Long-term functional outcomes of sofosbuvir-based antiviral treatment were evaluated in a cohort study involving 16 Italian centres within the international compassionate use programme for post-transplant hepatitis C virus (HCV) recurrence. Seventy-three
Burra, Patrizia, Romano, Antonietta, Russo, Francesco Paolo   +2 more
core   +1 more source

Drug Repurposing of Approved Drugs Elbasvir, Ledipasvir, Paritaprevir, Velpatasvir, Antrafenine and Ergotamine for Combating COVID19 [PDF]

, 2020
Vishal Mevada, Pravin Dudhagara, Himani Gandhi, Nilam Vaghamshi, Urvisha Beladiya, Rajesh Patel   +5 more
openalex   +1 more source

Effectiveness and Safety of Sofosbuvir/Ledipasvir and Paritaprevir/ritonavir/Ombitasvir + Dasabuvir in Patients with Chronic Kidney Diseases: Results from ERCHIVES [PDF]

, 2017
Adeel A. Butt, Yanjie Ren, Amy Puenpatom, Jean Marie Arduino, Ritesh Kumar, Abdul‐Badi Abou‐Samra   +5 more
openalex   +1 more source

Successful Pre- and Posttransplant Sofosbuvir-Based Anti-Hepatitis C Virus Treatment in Persons Living With Human Immunodeficiency Virus Infection [PDF]

, 2017
This retrospective study reports the data of sofosbuvir-based anti-hepatitis C virus treatment in 24 candidates and 24 recipients of liver transplantation coinfected with human immunodeficiency virus. Sustained virologic response was cumulatively 85% (90%
Badia, Lorenzo, Beghetto, Barbara, Dolci, Giovanni, Guaraldi, Giovanni, Magliano, Anna, Moioli, Maria Cristina, Nardini, Giulia, Pasulo, Luisa, Puoti, Massimo, Rossotti, Roberto, Tavio, Marcello, Verucchi, Gabriella   +11 more
core   +1 more source

LBP‐016: Lost to follow‐up among Ledipasvir/sofosbuvir treated patients in Canada: The BC Hepatitis Testers Cohort [PDF]

, 2018

openalex   +1 more source

Sofosbuvir based treatment of chronic hepatitis C genotype 3 infections-A Scandinavian real-life study [PDF]

, 2017
Background and aims Chronic hepatitis C virus (HCV) genotype 3 infection with advanced liver disease has emerged as the most challenging to treat. We retrospectively assessed the treatment outcome of sofosbuvir (SOF) based regimes for treatment of HCV ...
Balslev, Ulla, Belard, Erika, Dalgard, Olav, Farkkila, Martti, Hallager, Sofie, Heggelund, Lars, Karlsen, Lars, Kjaer, Mette Skalshoi, Krarup, Henrik, Lagging, Martin, Laursen, Alex Lund, Madsen, Lone G., Noraberg, Geir, Ovrehus, Anne, Roge, Birgit Thorup, Weiland, Ola, Weis, Nina   +16 more
core   +4 more sources

HCV Drug Resistance Challenges in Japan: The Role of Pre-Existing Variants and Emerging Resistant Strains in Direct Acting Antiviral Therapy

Viruses, 2015
Sustained virological response (SVR) rates have increased dramatically following the approval of direct acting antiviral (DAA) therapies. While individual DAAs have a low barrier to resistance, most patients can be successfully treated using DAA ...
Kazuaki Chayama, C. Nelson Hayes
doaj   +1 more source